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Peptidoglycan Molecular Requirements Allowing Detection by
the Drosophila Immune Deficiency Pathway1
Carolyn R. Stenbak,2* Ji-Hwan Ryu,2† Franc¸ois Leulier,3* Sebastien Pili-Floury,*
Claudine Parquet,‡ Mireille Herve´,‡ Catherine Chaput,§ Ivo G. Boneca,§ Won-Jae Lee,†
Bruno Lemaitre,4* and Dominique Mengin-Lecreulx‡
Innate immune recognition of microbes is a complex process that can be influenced by both the host and the microbe. Drosophila
uses two distinct immune signaling pathways, the Toll and immune deficiency (Imd) pathways, to respond to different classes of
microbes. The Toll pathway is predominantly activated by Gram-positive bacteria and fungi, while the Imd pathway is primarily
activated by Gram-negative bacteria. Recent work has suggested that this differential activation is achieved through peptidoglycan
recognition protein (PGRP)-mediated recognition of specific forms of peptidoglycan (PG). In this study, we have further analyzed
the specific PG molecular requirements for Imd activation through the pattern recognition receptor PGRP-LC in both cultured
cell line and in flies. We found that two signatures of Gram-negative PG, the presence of diaminopimelic acid in the peptide bridge
and a 1,6-anhydro form of N-acetylmuramic acid in the glycan chain, allow discrimination between Gram-negative and Gram-
positive bacteria. Our results also point to a role for PG oligomerization in Imd activation, and we demonstrate that elements of
both the sugar backbone and the peptide bridge of PG are required for optimum recognition. Altogether, these results indicate
multiple requirements for efficient PG-mediated activation of the Imd pathway and demonstrate that PG is a complex immune
elicitor. The Journal of Immunology, 2004, 173: 7339–7348.
I nnate immunity provides a first line of defense against in-vading organisms. This response is initiated by host patternrecognition receptors (PRRs),5 which sense specific and
highly conserved motifs found in microbes, but not in the host,
such as LPS, peptidoglycan (PG), lipoproteins, and CpG DNA (1).
Upon recognition, the host receptor activates signaling cascades
that result in the expression of immune effectors and regulators. In
vertebrates, the most widely studied class of PRRs is the TLRs,
originally named based on their homology to the Drosophila Toll
protein. TLRs are transmembrane proteins that have been shown to
initiate signaling cascades that ultimately regulate the immune re-
sponse via NF-B (2). It has been shown that TLR4, in association
with two cofactors, MD2 and CD14, specifically recognizes LPS,
found exclusively in Gram-negative bacterial cell walls, while
TLR2 recognizes lipoproteins from various bacterial cell walls (2).
Nods, a newly identified class of PRRs in mammals that, unlike
TLR, recognize bacterial products in the cytoplasm of cells, are
activated by PG. A unique muropeptide derived from Gram-neg-
ative PG, containing a diaminopimelic acid (DAP) residue, has
been shown to be specifically recognized by Nod1, while Nod2
detects a PG muropeptide found in all types of bacteria (3–6).
Thus, it is thought that TLRs and Nods can detect the presence of
different types of infectious agents.
Drosophila, in contrast to mammals, lacks adaptive immunity
and therefore relies entirely on innate mechanisms of immunity for
defense against invading microorganisms (7–9). Similar to mam-
malian innate immunity, pathogens are recognized through inter-
actions of microbial compounds and PRRs in Drosophila. Toll and
TLRs share structural and functional similarities; however, while
TLRs interact with microbial components, Toll does not. Instead,
the Drosophila extracellular protein Spaetzle, found in the hemo-
lymph (blood), is proteolytically cleaved to activate the Toll re-
ceptors on the surface of the fat body (an analogue of the liver) and
initiate a signaling cascade that results in the expression of anti-
microbial genes via the NF-B proteins Dif and Dorsal. Fat body
cells contain a second, Toll-independent signaling cascade called
the immune deficiency (Imd) pathway, which also induces the ex-
pression of antibacterial peptide genes such as Diptericin via the
third NF-B trans activator Relish (7–10). The Toll pathway is
activated largely by Gram-positive bacteria and fungi, and it con-
trols the expression of the antifungal peptide gene Drosomycin,
while the Imd pathway is triggered mostly by Gram-negative and
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Bacillus-type bacteria, and it controls the expression of the anti-
bacterial peptide gene Diptericin (11). Thus, the immune system in
Drosophila demonstrates how two distinct signaling pathways can
modulate the expression of genes in response to different classes of
microbes, and serves as a simple model of innate immune response
in animals.
In Drosophila, it has been shown that bacterial recognition is
achieved, at least in part, through PG recognition proteins
(PGRPs). PGRPs are found in many species, including insects and
mammals, and have been shown to bind directly to PG (12–16).
PGRP-SA, a secreted protein circulating in the hemolymph, has
been shown to activate the Toll pathway in response to Gram-
positive bacteria, but not fungal infection (17), while PGRP-LC
acts as a transmembrane receptor upstream of the Imd pathway
(18–20). In addition, PGRP-LE, which encodes a secreted PGRP,
can activate the Imd pathway when overexpressed in flies. How-
ever, the exact function of PGRP-LE in the Drosophila immune
response awaits loss-of-function analysis (21). A second group of
newly identified pattern recognition molecules in Drosophila is the
Gram-negative binding proteins (GNBPs) (22). GNBP1 appears to
function as a secreted microbial recognition factor that, like PGRP-
SA, regulates the Toll pathway in response to Gram-positive bac-
teria (23, 24).
Despite the identification of recognition proteins, the bacterial
products recognized by the Toll and Imd pathways remain unclear.
It has long been assumed that LPS is a major determinant in the
specific recognition of Gram-negative bacteria, given its exclusive
presence on the surface of these bacteria. Recently, using highly
purified products, we have demonstrated that, in contrast to ver-
tebrates, LPS is not the main determinant for Gram-negative bac-
terial recognition. Rather, we found that the ability of Drosophila
to discriminate between Gram-positive and Gram-negative bacte-
ria relied on the recognition of specific forms of PG (25). The
structure of PG from Bacillus and Gram-negative bacteria differs
from that of most Gram-positive PG in the third amino acid posi-
tion of the peptide bridge. Gram-negative and Bacillus-type PGs
are cross-linked with a peptide containing a meso-diaminopimelic
(DAP) residue, whereas a lysine is found in this position in other
Gram-positive bacterial PGs (26). These data suggested that
PGRP-LC senses DAP-type PG from Gram-negative and Bacillus-
type bacteria, while PGRP-SA/GNBP1 may interact with lysine-
type PG found in most Gram-positive bacteria.
During the course of bacterial infection, the structure and mu-
ropeptide composition of PG are likely to be modified through the
action of host and bacterial enzymes. Therefore, to better under-
stand the mechanisms underlying bacterial recognition in Dro-
sophila, it is necessary to define the PG structural requirements
allowing detection by PGRPs. Using cell culture and in vivo as-
says, we have analyzed an extensive array of PG products and
derivatives, either naturally occurring or synthetically engineered,
for their capacity to activate the Imd pathway. We have also tested
the immunostimulatory properties of PG that have been processed
by different bacterial enzymes. This work allows us to define the
specific PG requirements for innate immune detection and pro-
vides new insights into Gram-negative bacterial recognition in
Drosophila.
Materials and Methods
Fly stocks
ORR, DD1 (y, w, P(ry, Diptericin-lacZ), P(w, Drosomycin-GFP)), or
the 8871A (w, P(w, Drosomycin-lacZ)) flies were used as wild-type
strains (27). Diptericin-lacZ is a P transgene inserted on the X chromosome
containing a fusion between 2.2 kb of upstream sequence from the Dip-
tericin gene and the coding sequences from the -galactosidase gene.
Drosomycin-lacZ is a P transgene inserted on the X chromosome contain-
ing a fusion between 2.4 kb of upstream sequence from Drosomycin gene
and the coding sequences from the -galactosidase gene. The PGRP-LCE
allele is described elsewhere (19). Drosophila stocks were maintained at
25°C using standard medium.
Injection and LacZ measurements
A total of 9.2 nl of solution (water or bacterial extracts) was injected into
the thorax of female adults (3–4 days old) using a Nanoject apparatus
(Drummond Scientific, Broomall, PA). After injection, Dpt-lacZ or Drs-
lacZ flies were incubated for 6 or 24 h at 25°C. LacZ measurements were
previously described (11). The injection procedure creates an injury that,
by itself, triggers a significant induction of the Diptericin and Drosomycin
reporter genes; therefore, the measurements of -galactosidase activity
monitored after injection of microbial compounds were normalized to the
value obtained with water injection using the same conditions.
Digestions of PGs
Digestions of 100 g of purified Escherichia coli PG with muramidase
(mutanolysin, 50 g) and Slt transglycosylase (10 g) were done in 20 mM
potassium phosphate buffer (pH 6.5) and 300 mM sodium acetate buffer
(pH 4.5), respectively. Reaction mixtures (200 l) were incubated over-
night at 37°C. We have controlled that the polymer was digested to almost
completion (at least 95%) by isolation and quantitation of the soluble frag-
ments generated during this process. A residual (5%) nondegradable mate-
rial is always observed following these treatments (probably highly cross-
linked material). Entire digest solutions were used in our experiments.
Cell culture, immune stimulations, and quantitative
real-time PCR
Drosophila mbn-2 cells were maintained in Schneider medium (Sigma-
Aldrich, St. Louis, MO) supplemented with 10% heat-inactivated FBS. In
the case of immune stimulation, cells were incubated with various bacterial
components at different concentrations for 6 h. Quantitative analysis of
Diptericin expression was performed, as described previously (25). Briefly,
total RNA was extracted from cells and cDNA was synthesized by using
First cDNA synthesis kit (Roche, Basel, Switzerland), according to man-
ufacturer’s instructions. Fluorescence real-time PCR was performed using
dsDNA dye SYBR Green (PerkinElmer, Boston, MA). SYBR Green anal-
ysis was performed on an ABI PRISM 7700 system (PerkinElmer) using
manufacturer’s instructions. Primer pairs for Diptericin and control Rac2
were used to detect target gene transcripts. All samples were analyzed in
triplicate, and the amount of mRNA detected was normalized relative to the
control Rac2 values.
RNA interference
Linear DNA containing the PGRP-LC sequence, flanked by a T7 promoter
on each side, was purchased from Open Biosystems (Huntsville, AL). The
dsRNA was produced by in vitro transcription (Ribomax large scale RNA
production system T7 kit; Promega, Madison, WI). For RNA interference
(RNAi), Drosophila mbn-2 cells were diluted to a final concentration of
1  106 cells/ml in serum-free Schneider medium. dsRNA was added (15
g) directly to the medium with vigorous agitation. The cells were incu-
bated for 30 min at 25°C, followed by addition of 2 ml of Schneider
medium containing 10% FBS. The cells were incubated for 4 days before
PG stimulation.
Synthesis and purification of PGs and muropeptides
The chemical synthesis of meso-DAP, meso-lanthionine, and L-allo-cysta-
thionine has been previously described (28). Total replacement of DAP by
lanthionine or cystathionine in the PG of E. coli was obtained by growing
the DAP auxotrophic strain 243 in minimal medium supplemented with
either of the two DAP analogues, as previously described (29). Extensive
replacement (50%) of DAP by L-lysine in the PG of E. coli was obtained
by transforming cells with the pMuSa2 plasmid that overexpresses the
Staphylococcus aureus murE gene encoding UDP-N-acetylmuramic acid
(MurNAc)-L-Ala-D-Glu:L-lysine ligase (30). PG from E. coli and other bac-
terial species were isolated and purified, as previously described (25).
Plasmids allowing overproduction of E. coli enzymes that cleave spe-
cific bonds in the PG structure were constructed. To allow a simple puri-
fication, these proteins were expressed as fusions possessing a His6-tag at
the N terminus. The sltY gene encoding SltY transglycosylase (31) was am-
plified by PCR from E. coli chromosome using oligonucleotides 5-GGC
GAGATCTGACTCACTGGATGAGCAGCGTAGTC-3 and 5-TCATA
AGCTTGCGGATCAGTAACGACGTCCCC-3 as primers. The resulting
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fragment was cut by BglII and HindIII and cloned between the compatible
BamHI and HindIII sites of vector pET2130, a pET21d derivative, gener-
ating plasmid pMLD204. The ldcA gene encoding L,D-carboxypeptidase
(32) and the nagZ gene encoding -N-acetylglucosaminidase (33) were
similarly amplified, using oligonucleotides 5-AGGAGGATCCAT
GTCTCTGTTTCACTTAATTGCC-3 and 5-GCAGCTGCAGCGTTT
TACTTAGCCCTGAAGCGTG-3, and 5-GGAGGGATCCGTGGGTC
CAGTAATGTTGGATGTCGAAG-3 and 5-CATACTGCAGGGTTAGT
GACCTGCTTTCTCTTCCTG-3 as primers, respectively. The resulting
fragments were cut by BamHI and PstI and cloned between the same sites
of vector pTrcHis30 (34), generating pMLD210 and pMLD211, respec-
tively. These plasmids were transformed in the appropriate host strains,
BL21(DE3)pLysS or DH5, and the different proteins were overproduced
(isopropyl -D-thiogalactoside induction) and purified from the soluble cell
fraction on Ni2-nitrilotriacetate agarose, essentially following the manu-
facturer’s recommendations (Qiagen, Valencia, CA). For the generation of
anhydro-containing PG fragments, PG purified from E. coli mutant strain
BW25113 lpp::CmR that do not express the Lpp lipoprotein (25) was
treated with E. coli SltY transglycosylase. The reaction mixture (0.5 ml)
containing 300 mM sodium acetate buffer, pH 4.5, 500 g of PG (briefly
sonicated for homogeneization), and pure His6-tagged SltY enzyme (40
g) was incubated overnight at 37°C. The reaction was stopped by adding
500 l of 50 mM sodium phosphate buffer, pH 4.45 (HPLC eluent A), and
2 l of phosphoric acid. The main products generated were the monomer
and dimer forms of N-acetylglucosamine (GlcNAc)-MurNAc(anhydro
(anh))-tetrapeptide, but other minor tripeptide- or glycine-containing frag-
ments were also observed that reflect the complexity of the PG structure,
as reported by Glauner et al. (35). These different products were purified by
HPLC on a Nucleosil 5C18 column (4.6  250 mm) using an isocratic
elution with eluent A at 0.6 ml/min for 20 min, followed by a gradient of
methanol from 0 to 25% in eluent A applied between 20 and 80 min (peaks
were detected at 215 nm). Purified compounds were lyophilized, dissolved into
water, and applied on the same HPLC column for desalting, using this time
0.1% trifluoroacetic acid and a gradient of methanol for elution. MurNAc(anh)
peptides were obtained by treatment of GlcNAc-MurNAc(anh) peptides with
E. coli NagZ  N-acetylglucosaminidase. The reaction mixture (200 l) con-
tained 20 mM HEPES buffer, pH 7.4, 50 mM NaCl, 0.5 mM substrate, and
pure His6-tagged NagZ enzyme (20 g). GlcNAc-MurNAc(anh) tripeptides
and MurNAc(anh) tripeptides were generated by treatment of the correspond-
ing tetrapeptide compounds with E. coli LdcA L,D carboxypeptidase. The reac-
tion mixture (200 l) contained 50 mM Tris-HCl buffer, pH 8.0, 0.5 mM
substrate, and pure His6-tagged LdcA enzyme (20 g). GlcNAc-MurNAc(anh)
was obtained by treatment of GlcNAc-MurNAc(anh) tetrapeptide with par-
tially purified N-acetylmuramoyl-L-alanine amidase from E. coli. In all
cases, incubations were performed overnight at 37°C and products were
purified and desalted by HPLC, as described above. MurNAc peptides
were generated by mild acid hydrolysis (0.1 M HCl, 10 min at 100°C) of
the corresponding UDP-MurNAc peptides. Lactoyl peptides were gener-
ated by treatment of MurNAc peptides with 4 M ammonium hydroxide for
5 h at 37°C. After neutralization of the reaction mixtures with one equiv-
alent of acetic acid, they were purified by HPLC, as described above, using
0.1% trifluoroacetic acid as eluent. Free peptides were obtained by treat-
ment of the MurNAc peptides with partially purified E. coli amidase, as
described above. Amino acid and amino sugar compositions were deter-
mined with an Hitachi L8800 amino acid analyzer (ScienceTec, Les Ulis,
France) after hydrolysis of samples in 6 M HCl for 16 h at 95°C. The
structure and purity of isolated PG fragments and synthesized compounds
were also confirmed by MALDI-TOF mass spectrometry.
To obtain GlcNAc-MurNAc(anh) dipeptide, we used PG purified from
Helicobacter pylori strain 26695 during stationnary phase (with contains a
high amount of GlcNAc-MurNAc dipeptide) and treated it with E. coli
SltY. The reaction mixture containing 10 mM sodium acetate buffer, pH
4.5, 10 mM magnesium chloride, 200 g of H. pylori PG, and pure His6-
tagged SltY enzyme (20 g) was incubated overnight at 37°C. The reaction
was stopped by boiling during 10 min. Anhydrous products and particu-
larly GlcNAc-MurNAc(anh) dipeptide were purified and then desalted by
HPLC like E. coli PG products. We confirmed the nature of GlcNAc-
MurNAc(anh) dipeptide by MALDI-TOF mass spectrometry.
Results
PGs containing DAP, but not lysine, induce Diptericin
expression
We have previously shown that DAP-containing PGs extracted
from two Gram-negative bacterial species (E. coli and Pseudomo-
nas aeruginosa) and two Gram-positive species (Bacillus thurin-
giensis and Bacillus subtilis) induce the Imd pathway via PGRP-
LC. In contrast, PGs extracted from two Gram-positive bacteria
(Enterococcus faecalis and Micrococcus luteus) strongly induce
the GNBP1/PGRP-SA Toll pathway, but fail to activate the Imd
pathway (24, 25). A structural comparison of the different PGs
revealed that those able to activate the Imd pathway have DAP
present in the third position of the peptide bridge, while those that
did not activate the Imd pathway contain lysine at the same posi-
tion. This suggests a pivotal role for DAP and Lys in the specific
induction of either the Imd or Toll pathways, respectively. To fur-
ther examine this idea, a larger panel of highly purified PGs was
analyzed for the ability to induce the Toll and Imd pathways. Two
additional PGs from Gram-negative bacterial species (H. pylori
and Neisseria meningitidis), one DAP-containing PG from a
Gram-positive bacteria (Listeria monocytogenes), and one Lys-
type PG from a Gram-positive species (S. aureus) were extracted
and purified. This panel of bacterial PGs was analyzed in vivo
using microinjection of the PG into Drosophila containing either a
Diptericin(Dpt)-lacZ or Drosomycin(Drs)-lacZ reporter gene. The
expression of these two antimicrobial genes is tightly regulated by
the Imd and Toll pathways, respectively, and accurately reflects
their specific activation (25). In agreement with our previous re-
sults, all of the Gram-negative PGs, as well as the Bacillus-type
PGs, induced Dpt expression in vivo, while the Gram-positive PGs
showed no induction (Fig. 1A). In contrast, the Gram-negative and
Bacillus-type PGs showed a weak activation of Drs expression,
while the Gram-positive PGs strongly induced Drs (Fig. 1B).
These results confirm and extend our previous findings that DAP-
containing PGs induce Dpt while Lys-containing PGs do not.
We next analyzed Dpt expression in mbn-2 cells, a Drosophila
cell line derived from larval hemocytes that contains a functional
Imd pathway, in response to the panel of PGs. The mbn-2 cell line
strongly responds to Gram-negative PG (25), and therefore pro-
vides a more sensitive assay with which to monitor Imd pathway
activity. The Diptericin gene was monitored by quantitative RT-
PCR 6 h after treatment with PGs, commercial LPS, or water as an
internal control. The four different Gram-negative bacterial PGs
containing DAP (P. aeruginosa, E. coli, H. pylori, and N. menin-
gitidis) all induced Dpt at both low and high concentrations (Fig.
1C). The level of induction observed was significantly higher than
the level observed with commercial LPS, which induces only at
high concentration due to the presence of PG contaminants (25).
The two Bacillus-like PGs containing DAP (B. subtilis and L.
monocytogenes) also showed Dpt induction in mbn-2 cells, but
only at high concentrations (Fig. 1C). In contrast, the Gram-pos-
itive Lys-containing PGs (E. faecalis and S. aureus) showed no
measurable induction of Dpt, even at high concentrations. These
results support the idea that the DAP residue is an important de-
terminant of Imd pathway activation by PG, but also suggest that
DAP may not be the sole determinant given that Bacillus-type PGs
with DAP induced Dpt with reduced efficiency compared with
Gram-negative PGs.
PGs containing analogues of DAP still activate Diptericin
expression
To further test the role of meso-DAP in Imd-dependent detection
of PG, PG preparations that differ only in the nature of the third
amino acid residue were generated. E. coli  243, a strain mutated
for the dapA gene and therefore unable to synthesize DAP, was
grown in the presence of either meso-DAP or one of two DAP
analogues, L-allo-cystathionine or meso-lanthionine. It has been
shown that Nod1, which recognizes the PG-derived tripeptide
L-Ala--D-Glu-meso-DAP, stringently requires DAP for this rec-
ognition and is weakly activated by tripeptides containing these
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two analogues (6, 36). Mbn-2 cells were treated for 6 h with pu-
rified PGs containing either DAP or one of its analogues at the
third position of the peptide bridge. Quantitative RT-PCR for Dpt
expression showed that all three PGs were able to induce to similar
levels at both low and high concentration (Fig. 2). The results
obtained in vivo using injection of the PGs containing DAP or
analogues corroborated these results (data not shown). Taken to-
gether, these data show that PGs containing analogues of DAP are
able to efficiently induce Dpt expression, and demonstrate that the
Imd pathway recognition of the DAP residue in Gram-negative PG
is not as discriminating as that seen for Nod1.
Muramidase-treated PGs show decreased capacity to induce
Diptericin expression in mbn-2 cells
PG is a large polymer that consists of long glycan chains of alter-
nating GlcNAc and MurNAc residues that are cross-linked by
short peptide bridges. PG polymers can be degraded by enzymes
such as muramidase and vertebrate lysozyme that catalyze the
cleavage of the -1,4 bond between MurNAc and GlcNAc in gly-
can strands to generate muropeptides (Fig. 3). Previous results
demonstrated that cleavage of Gram-negative PG polymers into
individual subunits by muramidase treatment prevented Dpt induc-
tion in vivo (25) (Fig. 4B). These studies have been extended in
mbn-2 cells, and the results show that indeed the muramidase treat-
ment of both P. aeruginosa and E. coli PG significantly reduced
the level of Dpt induction (Fig. 4A). However, in contrast to the in
vivo assay (Fig. 4B), muramidase-treated PG was still able to in-
duce Dpt expression, demonstrating that muramidase treatment re-
duces, but does not eliminate the ability of PG to induce Dpt in cell
culture. These results show that some muropeptides produced by
muramidase treatment are still capable of being recognized by the
PGRP-LC/Imd pathway in mbn-2 cells, but suggest that PG oli-
gomerization is important for optimum stimulation in vivo.
SltY-treated PGs retain the capacity to induce Diptericin
expression in mbn-2 cells and flies
In E. coli, SltY, a bacterial soluble lytic transglycosylase, cleaves
the -1,4 bond between MurNAc and GlcNAc in glycan strands to
generate muropeptides, similar to muramidases (37). However, un-
like muramidase, SltY cleavage also results in the unique forma-
tion of an internal 1,6-anhydro bond in the cleaved MurNAc res-
idue (Fig. 3). The anhydro form of MurNAc is naturally present in
Gram-negative bacteria at the extremity of all glycan strands, and
consequently is present in5% of the GlcNAc-MurNAc repeating
units (35). Thus, each E. coli PG muropeptide generated by SltY
digestion will contain the 1,6-anhydro bond, while PG digested
with muramidase generates muropeptides, of which only 5%
contain the anhydro bond. To further examine the importance of
this MurNAc 1,6-anhydro bond in Imd activation, E. coli PG was
digested with SltY and analyzed for its ability to induce Dpt in
mbn-2 cells. Surprisingly, we observed that SltY-digested PG re-
tained the capacity to induce the Dpt gene. At both low and high
FIGURE 1. Immune induction by PG from various bacteria. A, Induc-
tion of Dpt-lacZ expression in vivo after injection of purified bacterial PGs.
Adult female flies carrying the Dpt-lacZ reporter gene were microinjected
with 9.2 nl of PG extracted from P. aeruginosa (P.a.), E. coli (E.c.), and
E. faecalis (E.f.), at 5 mg/ml, or PG from H. pylori (H.p.), N. meningitidis
(N.m.), L. monocytogenes (L.m.), B. subtilis (B.s.), and S. aureus (S.a.) at
10 mg/ml. -Galactosidase activity was measured 24 h postinjection. B,
Induction of Drs-lacZ expression after injection of purified bacterial PGs.
Injections of PGs were performed, as described above, using adult female
flies carrying the Drs-lacZ reporter gene. -Galactosidase activity was
measured 24 h postinjection. C, Induction of Dpt expression in mbn-2 cells
6 h after treatment with purified bacterial PGs. Cells were incubated with
a final concentration of 0.05 g/ml (u) and 5 g/ml (f) PG extracted from
P. aeruginosa (P.a.), E. coli (E.c.), H. pylori (H.p.), N. meningitidis (N.m.),
L. monocytogenes (L.m.), B. subtilis (B.s.), E. faecalis (E.f.), S. aureus
(S.a.), and commercial LPS (Sigma-Aldrich) Total RNA was extracted
from cells, and Dpt and rac expression was monitored with quantitative
fluorescence real-time RT-PCR.
FIGURE 2. E. coli PG containing analogues of DAP activate the Imd
pathway. Induction of Dpt expression in mbn-2 cells 6 h after treatment
with purified E. coli PGs. Cells were incubated with 0.05 or 5 g/ml PG
extracted from an E. coli strain incapable of synthesizing DAP (E. coli 
243) and grown in the presence of meso-DAP, meso-lanthionine (LAN), or
L-allo-cystathionine (CYS). Total RNA was extracted from cells 6 h after
treatment, and Dpt and rac expression was monitored with quantitative
fluorescence real-time RT-PCR.
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concentration, the digested PG showed a level of induction similar
to or greater than the undigested PG (Fig. 5A).
To determine whether SltY-digested PG could induce Dpt in
vivo, the same preparations along with similar preparations of di-
gested P. aeruginosa PG were microinjected into Dpt-lacZ flies.
We observed that the SltY-digested PGs were able to efficiently
induce Dpt expression (Fig. 5B). This mirrors the results from the
cell culture experiments and supports the idea that the anhydro
bond plays a critical role in immune recognition by the Imd
pathway.
GM(anh)-tetraDAP activates the Imd pathway in mbn-2 cells and
in vivo
PG digestion by SltY generates a high proportion of GlcNAc-
MurNAc(anh)-L-Ala--D-Glu-meso-DAP-D-Ala (GM(anh)-tetraDAP),
a monomer also known as tracheal cytotoxin (Fig. 6). This PG
fragment was originally isolated from the supernatants of Borde-
tella pertussis cultures, and was shown to damage hamster tracheal
epithelial cells (38). HPLC-purified GM(anh)-tetraDAP from SltY-
digested PG was tested for its capacity to induce the Imd pathway
in mbn-2 cells and in flies. Fig. 7A indicates that GM(anh)-
tetraDAP induced Dpt expression in mbn-2 cells at a high level,
indicating that this muropeptide is an active compound recognized
by the Imd pathway. To verify that Imd activation by GM(anh)-
tetraDAP was PGRP-LC dependent, RNAi was designed to target
the common region of all PGRP-LC isoforms (39). Inactivation of
all PGRP-LC isoforms in mbn-2 cells prevented activation by
either GM(anh)-tetraDAP or Gram-negative PG (Fig. 7B). This effect
was specific of PGRP-LC because inactivation of PGRP-SA by
RNAi had no effect on the induction of Dpt by either GM(anh)-
tetraDAP or Gram-negative PG (data not shown). At high concen-
trations, GM(anh)-tetraDAP was also able to significantly induce
Dpt in vivo, although to levels lower than seen with polymeric PG
(Fig. 7C). Dpt expression by GM(anh)-tetraDAP was reduced in
PGRP-LC-deficient flies (Fig. 7D). These results demonstrate that
the SltY-digestion product, GM(anh)-tetraDAP, has the ability to
activate the PGRP-LC/Imd pathway and suggest that DAP in
conjunction with the anhydro form of MurNAc is important for
immune recognition and activation.
The third amino acid of the PG peptide bridge is important for
selective Imd and Toll pathway activation
Our initial results suggested a pivotal role for the third amino acid
in selective activation of either the Toll or Imd pathways. To fur-
ther test this hypothesis, we produced a synthetic analogue of
GM(anh)-tetraDAP in which the meso-DAP is replaced by an L-
lysine using an engineered E. coli strain. This analogue is artificial
because MurNAc anhydro bonds are not naturally found in Gram-
positive PG (40). We found that the presence of Lys reduced the
stimulatory capacity of the muropeptides in mbn-2 cells and in
flies by at least 2-fold, supporting our earlier results (Fig. 7, A and
C). We also observed that the GlcNAc-MurNAc(anh)-L-Ala--D-
Glu-L-Lys-D-Ala (GM(anh)-tetraLys) analogue weakly activated
the Drs gene when injected in the fly, while the GM(anh)-tetraDAP
did not (Fig. 7E). Because the two muropeptides differ only in their
third amino acid residue, our results demonstrate that this residue
plays a critical role in the selective activation of the Toll and Imd
pathways.
The anhydro bond of GM(anh)-tetraDAP is critical for optimum
activation of the Imd pathway
Both GM(anh)-tetra with DAP and with Lys contain the anhydro
form of MurNAc. Interestingly, muropeptides with anhydro bonds
are found in Gram-negative bacteria and at a lower level in Ba-
cillus species during germination, but not in lysine-type PG from
other Gram-positive bacteria (41). Thus, the presence of the Mur-
NAc anhydro bond, in addition to the presence of DAP, is a sig-
nature of Gram-negative PG and correlates well with the capacity
to activate the Imd pathway. To further test the importance of this
bond, an analogue of GM(anh)-tetraDAP lacking the anhydro bond
was generated (Fig. 6). This muropeptide, GM-tetraDAP, which
corresponds to the main monomer that is generated after murami-
dase treatment of polymeric PG, weakly induced the Dpt gene in
mbn-2 cells, showing a 2.5-fold lower activation level as compared
with GM(anh)-tetraDAP (Fig. 8A). These results demonstrate that
the anhydro bond of GM(anh)-tetraDAP plays a critical role in op-
timal recognition and induction in cell culture, and agree with the
results obtained with muramidase or SltY-digested PGs. The ob-
servation that GM(anh)-tetraLys, which still contains the MurNAc
FIGURE 3. Diagram of PG structure and cleavage sites of murein hydrolases. PG is a complex heteropolymer consisting of long glycan chains of
alternating GlcNAc and MurNAc residues, connected by cross-linking of short peptide bridges. All the terminal MurNAc residues ending the E. coli PG
glycan chains have a unique internal 1,6-anhydro bond. The PG fragment circled represents one PG subunit. Both lytic transglycosylases and muramidases
catalyze the cleavage of the -1,4-glycosidic bond between the MurNAc and GlcNAc residues. However, the bacterial transglycosylases catalyze an
additional intramolecular transglycosylation reaction that results in the formation of a 1,6-anhydro MurNAc residue.
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anhydro bond, retains a weak capacity to activate the Imd pathway
in mbn-2 cells and flies (Fig. 7, A and C) while intact PG from
Gram-positive bacteria does not, further supports the importance
of the anhydro bond. Thus, both DAP and the MurNAc anhydro
bond contribute to the stimulatory effect of GM(anh)-tetraDAP.
Multiple PG requirements for optimal Imd stimulation
To identify the minimal active PG muropeptide, we generated a
larger panel of E. coli muropeptides and PG derivatives and ana-
lyzed their effect on Dpt expression in mbn-2 cells and flies (Fig.
6). The first component of the GM(anh)-tetraDAP molecule that
was analyzed was the fourth amino acid of the peptide bridge. Fig.
8B shows that the GlcNAc-MurNAc(anh)-L-Ala--D-Glu-meso-
DAP (GM(anh)-triDAP) induced the Dpt gene at levels similar to
GM(anh)-tetraDAP, indicating the fourth amino acid residue is not
required for optimal recognition. In agreement with this finding, a
muropeptide similar to the GM(anh)-tetraDAP, but that has the
fourth amino acid (D-Ala) replaced by a glycine, still retains its full
activity. Thus, the GM(anh)-triDAP is competent for immune rec-
ognition and activation.
Elements of either the sugar backbone or the peptide bridge
were next analyzed for their importance in Imd activation. Fig. 8A
shows that a derivative of GM(anh)-tetraDAP lacking the GlcNAc
sugar residue, M(anh)-tetraDAP, induced Dpt at a level 3-fold
lower than GM(anh)-tetraDAP, indicating the importance of the
GlcNAc residue for optimum recognition. To examine the impor-
tance of the peptide bridge, GM(anh) without peptide was gener-
ated. This derivative was unable to significantly induce Dpt (Fig.
8C), demonstrating that the presence of the peptide bridge is
important for activation. Additionally, GM(anh)-di, which lacks
the third and fourth amino acids, was unable to significantly induce
Dpt. Thus, a minimum of three residues, including DAP, is im-
portant for induction of the Imd pathway. Finally, we observed that
PG derivatives lacking the sugar moieties, ranging from the dipeptide
to the pentapeptide (Fig. 6), were not able to induce Dpt with either
DAP or Lys in the third amino acid position (Fig. 8D). These results
demonstrate that elements of both the sugar backbone and the peptide
bridge of PG are necessary to induce the Imd pathway.
The minimal optimum motif was found to be GM(anh)-triDAP, a
close analogue of GM(anh)-tetraDAP lacking the fourth amino acid.
Modification of the sugar moieties, the anhydro bond, and third
amino acid all resulted in decreased induction. Altogether, these
results indicate multiple requirements for efficient PG-mediated
activation of the Imd pathway. To further test this hypothesis, we
generated an analogue of GM(anh)-tetraDAP with two modifica-
tions to determine whether the effects were additive. A GM(anh)-
tetraDAP molecule lacking both the GlcNAc sugar residue and the
MurNAc anhydro bond, M-tetraDAP, was tested for its ability to
induce Dpt expression in mbn-2 cells. Although the absence of the
FIGURE 4. Muramidase-treated Gram-negative PG reduces, but does
not abolish Imd activation in mbn-2 cells. A, Induction of Dpt expression
in mbn-2 cells after treatment with untreated and muramidase-treated PGs.
Purified PG from both P. aeruginosa (P.a.) and E. coli (E.c.) was digested
with muramidase overnight. Mbn-2 cells were incubated with PGs at final
concentrations of either 0.05 or 5 g/ml, and quantitative RT-PCR was
performed with total RNA extracted 6 h posttreatment. B, Induction of
Dpt-lacZ expression in vivo after injection with untreated and muramidase-
treated PGs. Adult female flies carrying the Dpt-lacZ reporter gene were
injected with 9.2 nl of muramidase-treated or untreated PGs from E. coli
and P. aeruginosa (injection solution: 0.05 or 5 mg/ml). -Galactosidase
activity was measured 6 h postinjection.
FIGURE 5. SltY-treated Gram-negative PG activates the Imd pathway
in vivo and in mbn-2 cells. Induction of Dpt expression in mbn-2 cells and
in vivo by untreated and SltY-treated PGs. A, Purified PG from E. coli was
digested with SltY overnight. Mbn-2 cells were incubated with a final
concentration of either 0.05 or 5 g/ml PGs, and quantitative RT-PCR was
performed with total cellular RNA extracted 6 h posttreatment. B, Adult fe-
male flies carrying the Dpt-lacZ reporter gene were injected with 9.2 nl of
solutions containing 0.05 or 5 mg/ml SltY-treated or untreated E. coli and P.
aeruginosa PGs. -Galactosidase activity was measured 6 h postinjection.
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anhydro bond alone and the absence of the GlcNAc residue alone
resulted in a 2.5- and 3-fold reduction of expression, respectively,
both modifications together resulted in a 7-fold reduction in Dpt
expression (Fig. 8A). This confirms that the presence of both
GlcNAc and the MurNAc anhydro bond is required for optimal
Imd stimulation, and demonstrates that multiple PG factors can
cooperatively influence recognition and Imd pathway activation.
Discussion
During the past few years, significant progress has been made to-
ward our understanding of pathogen recognition. Microbial detec-
tion is emerging as a multistep process that ultimately requires
direct contact between a host PRR and a microbial molecule. Ad-
ditional host factors may be involved upstream of recognition in
the degradation of cell wall compounds and/or the transport of
microbial ligands to the receptors. In contrast, enzymes from the
microbe may modulate the course of infection by modifying li-
gands or controlling their release. A major difficulty in the field of
innate immunity is the complexity and diversity of the microbial
compounds that are recognized by the host, and, thus, one impor-
tant issue is to determine the global molecular requirements for
recognition of microbial ligands. Identification of minimal micro-
bial motifs that are recognized by the host is also prerequisite for
future structural studies as well as for determining the factors that
influence the outcome of microbial recognition.
The PGRP family is a conserved class of proteins found in both
insects and invertebrates that can function as either PRRs or ami-
dases (42–44). The PGRP/PG system in Drosophila is one of the
best-characterized mechanisms of bacterial detection by the innate
immune system. In this study, we have undertaken a detailed anal-
ysis of the PG requirements, allowing activation of the PGRP-LC/
Imd pathway in flies and in the hemocytic cell line mbn-2. We
found that multiple requirements participate in the stimulatory ef-
fects of PG.
Importantly, this study confirms and extends our previous work
showing that the Imd pathway is activated by Gram-negative PG,
but not by Lys-type PG from Gram-positive bacteria. Using
GM(anh)-tetraDAP and an analogue that differs only in the third
amino acid (GM(anh)-tetraLys), we now clearly demonstrate the
critical role of this amino acid. Interestingly, DAP-type PG from
Bacillus species showed a capacity to induce the Imd pathway only
at high concentration. An anhydro bond at the extremity of the
glycan strand is not usually found in PG from Bacillus species
except as a minor compound during the germination process (41).
The observation that Bacillus PG is a less potent inducer of the
Imd pathway might be explained by the fact that Bacillus PGs
contain a high proportion of amidated DAP, the fact that they lack
GM(anh)-tetraDAP-like muropeptides containing an anhydro bond,
or both. Our results show that the capacity of the fly to discriminate
between Gram-negative and Gram-positive bacteria involves the
ability to distinguish between DAP-type PG and Lys-type PG. The
recognition of GM(anh)-tetraDAP, a PG derivative specific to
Gram-negative bacteria, may further accentuate the discriminatory
capacity of the fly.
In our previous studies, we have shown that PG digested by
muramidase loses its activity when injected into flies, suggesting
that monomeric PG is not active. However, by using a cell culture
assay that is more sensitive, we now demonstrate that muramidase
treatment reduces, but does not abolish the capacity of PG to ac-
tivate the Imd pathway. These results clearly indicate that: 1) poly-
meric PG has a more potent stimulatory activity compared with
digested PG, and 2) PG fragments retain some activity. The mu-
ramidase treatment of Gram-negative PG generates predominantly
the monomer GM-tetraDAP and a low proportion of GM(anh)-
tetraDAP, the terminal monomer of the glycan chain that contains
a 1,6-anhydro MurNAc residue. Using HPLC-purified compounds,
we now demonstrate that the terminal subunit GM(anh)-tetraDAP is
FIGURE 6. Schematic representation of the E. coli PG-derived muropeptides used in this study.
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a potent inducer of the Imd pathway in mbn-2 cells and in flies,
while the main monomer GM-tetraDAP is poorly recognized. This
is also supported by our observation that PG treated with SltY, an
enzyme that generates only GM(anh)-tetraDAP fragments, shows
the same stimulatory ability as intact PG. The observation that
monomers without anhydro bond and blocked configuration do not
efficiently activate the Imd pathway clearly explains the differen-
tial stimulatory capacities of PG treated with muramidase
and SltY.
The anhydro bond locks the MurNAc residue of the GM(anh)-
tetraDAP into a fixed configuration, while other monomers gener-
ated by muramidase treatment have a MurNAc residue with a flex-
ible configuration, with the hydroxyl group on C1 of MurNAc
oscillating between  and  forms. Our results suggest that the
hydroxyl group in the  configuration, and possibly the fact that
the MurNAc residue is in a fixed position, is important for PGRP
recognition. This is also in agreement with our data showing that
the sugar backbone is essential for optimum recognition. We have
shown that polymeric PG, in addition to GM(anh)-tetraDAP muro-
peptide, is efficiently recognized by PGRP-LC despite the presence
of only a small percentage of subunits containing the MurNAc
anhydro bond. Furthermore, DAP-type PG polymers from Bacillus
can activate the Imd pathway even though under our growth con-
ditions they do not contain any PG subunits containing MurNAc
with an anhydro bond. This clearly indicates that both GM(anh)-
tetraDAP and muropeptides joined together in polymeric PG have
stimulatory capacities. Interestingly, the process of PG polymer-
ization results in a chain of alternating GlcNAc and MurNAc res-
idues, in which the hydroxyl groups on C1 of sugars are all fixed
in the  configuration. This suggests that having a fixed configu-
ration of the MurNAc residue may be sufficient to allow recogni-
tion, and may explain why only polymeric Gram-negative PG and
GM(anh)-tetraDAP, but not fragments generated by muramidase
treatment, have the capacity to activate strongly the Imd pathway.
According to this model, the absence of anhydro bonds in the
muropeptides of Gram-positive PG would result in the fact that
only polymeric PG, but not muropeptides from Lys-type PG could
be recognized by PGRP. This is supported by our previous and
current observations showing that muramidase-treated Lys-type
PG does not induce the Toll target Drosomycin even though the
Toll pathway in vivo assay that we use shows much greater sen-
sitivity than the assay used to monitor Imd pathway activity (25).
Also, a previous report demonstrated that the minimum structure
FIGURE 7. GM(anh)-tetraDAP activates the Imd pathway. Induction of
Dpt expression in mbn-2 cells after treatment with GM(anh)-tetraDAP,
GM(anh)-tetraLys, and purified Gram-negative PG. A, Mbn-2 cells were
treated with 1 M purified muropeptide fragments or 5 g/ml purified PG,
total RNA was extracted 6 h later, and Dpt expression was quantified using
fluorescence real-time RT-PCR. Independent experiments, each represent-
ing an average of three samples, are represented by single bars of different
color. B, Induction of Dpt expression in mbn-2 cells with and without
RNAi of PGRP-LC by GM(anh)-tetraDAP and PG. Mbn-2 cells were pre-
treated with dsRNA to inactivate the PGRP-LC gene, followed by incu-
bation with either GM(anh)-tetraDAP or PG. Total RNA was extracted 6 h
later and analyzed, as described above. C and E, Induction of Dpt-lacZ and
Drs-lacZ expression in vivo after injection with muropeptides and PGs.
Adult female flies were injected with 9.2 nl of solutions of purified muropep-
tides (100 M and 1 mM) or purified PG (5 mg/ml), and -galactosidase
activity was measured 6 (u) and 24 h (f) postinjection. D, Induction of Dpt-
lacZ expression in PGRP-LCE flies after injection with GM(anh)-tetraDAP
and PG. Wild-type flies and flies lacking the PGRP-LC gene were injected
with 9.2 nl of GM(anh)-tetraDAP (1 mM) or P. aeruginosa PG (5 mg/ml).
-galactosidase activity was measured 24 h postinjection.
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of Lys-type PG required for antibacterial peptide expression in the
silkworm Bombyx mori was two repeating GlcNAc-MurNAc sub-
units with peptide chains (45). This structure has the first MurNAc
residue with the hydroxyl group in the  configuration, and is
therefore rigid. Thus, it is possible that a fixed MurNAc configu-
ration is important for efficient recognition by both PGRP-LC and
PGRP-SA, and may influence the recognition of PGs from various
bacterial origins.
By comparing the activity of a large panel of natural and syn-
thetic muropeptides, some of them being generated for the first
time, we were able to demonstrate that the minimum active mu-
ropeptide is GM(anh)-triDAP. Additional deletion or modification
of this muropeptide resulted in a lower stimulating capacity. The
importance of the complexity of PG architecture is underscored by
the additive effect of some of the modifications. Recently, the
mammalian intracellular bacterial-sensing proteins Nods have also
been shown to recognize small PG fragments (36). The minimal
motif sensed by Nod1 was the tripeptide L-Ala--D-Glu-meso-
DAP, which contains the first three residues of a Gram-negative
PG peptide bridge, without the sugar backbone. In contrast, the
minimal motif recognized by Nod2, which can be found in all
bacteria, was MurNAc-L-Ala-D-Glu, a compound including the
MurNAc residue from the backbone and the first 2 aa of the pep-
tide bridge. Our study indicates that the minimum active PG motif
required for optimum activation of the PGRP-LC/Imd pathway is
larger and involves more subtleties than those required to activate
the Nod system. The use of PGs containing analogues of DAP also
suggests that the PGRP-LC/PG recognition is less stringent com-
pared with the Nod system. This is consistent with our finding that
there are multiple requirements for optimal PGRP-LC-mediated
PG recognition.
Very recently, another group has also analyzed in further detail
which components from Gram-negative bacteria can induce an im-
mune response. Kaneko et al. (46) confirmed our previous study
showing that Gram-negative PGs, but not LPS, stimulate the Imd
pathway. Using another Drosophila cell line, S2 treated with ec-
dysone, they also showed that GM(anh)-tetraDAP can activate the
Imd pathway. In contrast to our study, they observed that lactyl-
tetrapeptide can induce an immune response. However, the obser-
vation that they need 106 times more lactyl-tetrapeptide than
GM(anh)-tetraDAP indicates that lactyl-tetrapeptide is not likely to
be a physiological ligand. This is supported by our results, which
clearly show that the sugar backbone is important for optimum
recognition.
It remains surprising that flies can detect Gram-negative bacteria
on the basis of a microbial component that is present at the surface
of the inner membrane and is therefore hidden by the LPS-con-
taining outer membrane. This suggests that Gram-negative bacteria
may be degraded by humoral or cellular mechanisms that release
PG and elicit an antimicrobial response. Alternatively, PGRP-LC
may recognize the PG fragments that are continuously released
from Gram-negative bacteria as a consequence of PG structure
remodeling occurring during cell growth and division processes.
The observation that GM(anh)-tetraDAP is a potent activator of the
Imd pathway supports this second hypothesis because this mu-
ropeptide is known to be continuously released from the PG struc-
ture by lytic transglycosylases and reused for de novo synthesis of
PG in Gram-negative bacteria (47). GM(anh)-tetraDAP is also a
signature of Gram-negative bacteria given that this muropeptide is
not present in Lys-type PG from Gram-positive bacteria. There-
fore, recognition of GM(anh)-tetraDAP may be a way to efficiently
recognize Gram-negative bacteria, even though these bacteria con-
tain less PG and this cell-wall component is hidden underneath an
FIGURE 8. Characterization of the minimal PG motifs detected by
PGRP-LC. Induction of Diptericin was monitored in mbn-2 cells by RT-
PCR 6 h after treatment with GM(anh)-tetraDAP and related muropeptides
(1 M). Independent experiments, each representing an average of three
samples, are represented by single bars of different colors. A, Cells were treated
with GM(anh)-tetraDAP, GM-tetraDAP, M(anh)-tetraDAP, and M-tetraDAP. B,
Cells were treated with GM(anh)-tetraDAP, GM(anh)-triDAP, and GlcNAc-
MurNAc(anh)-L-Ala--D-Glu-meso-DAP-Gly (GM(anh)-tetraDAP-Gly). C, Cells
were treated with GM(anh)-tetraDAP, GM(anh), and GlcNAc-MurNAc(anh)-
L-Ala-D-Glu (GM(anh)-di). D, Cells were treated with GM(anh)-tetraDAP,
dipeptide -D-Glu-meso-DAP, tripeptides L-Ala--D-Glu-X, tetrapeptides
L-Ala--D-Glu-X-D-Ala, and pentapeptides L-Ala--D-Glu-X-D-Ala-D-Ala
(in which X is meso-DAP or L-Lys).
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outer layer of LPS. To date, it is not known whether other com-
ponents of bacterial cell walls are recognized by the Imd pathway.
In our hands, we found that a commercially available flagellin,
another proposed elicitor of the Imd pathway, did not activate the
Dpt gene in mbn-2 cells (data not shown).
In the last few years, we have learned more about the mecha-
nisms used by Drosophila to recognize bacteria. The identification
of the recognition proteins acting upstream of the Toll and Imd
pathways as well as the determination of the respective bacterial
ligands are opening the way to structural studies and to further
detailed studies of the host and bacterial factors influencing
recognition.
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